Overview

Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
A study in healthy volunteers to determine whether different drugs metabolised by the liver have any effects on how NRL972 is processed within the body.
Phase:
Phase 1
Details
Lead Sponsor:
Norgine
Treatments:
Cyclosporine
Cyclosporins
Rifampin